Qiagen NV is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown positive financial performance in the latest quarter and has received some analyst upgrades, the technical indicators and trading sentiment suggest a lack of immediate upward momentum. Additionally, hedge fund selling and bearish technical trends further indicate caution. Holding off for now may be a better strategy.
The stock is currently in a bearish trend with the MACD histogram below 0 and negatively contracting. RSI is neutral at 32.167, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 40.56, with key support at 39.479 and resistance at 41.641.

Revenue increased by 3.69% YoY in Q4
Net income grew by 22.09% YoY, and EPS improved by 28.95% YoY.
Analysts have raised price targets, with Deutsche Bank upgrading the stock to Buy.
Hedge funds are selling, with a 286.76% increase in selling activity last quarter.
Gross margin dropped by -6.85% YoY in Q4
Technical indicators suggest bearish momentum, and the stock has a 60% chance of declining over the next month.
In Q4 2025, Qiagen reported revenue of $540.42M, up 3.69% YoY. Net income increased to $107.83M, up 22.09% YoY, and EPS rose to 0.49, up 28.95% YoY. However, gross margin declined to 59.83%, down -6.85% YoY.
Analyst sentiment is mixed. Deutsche Bank upgraded the stock to Buy with a $54 price target, citing undemanding valuation and robust balance sheet. Other analysts raised price targets but maintained neutral or hold ratings, citing slower base business growth and skepticism around growth targets.